Cargando…

RGC32 induces epithelial-mesenchymal transition by activating the Smad/Sip1 signaling pathway in CRC

Response gene to complement 32 (RGC32) is a transcription factor that regulates the expression of multiple genes involved in cell growth, viability and tissue-specific differentiation. However, the role of RGC32 in tumorigenesis and tumor progression in colorectal cancer (CRC) has not been fully elu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiao-Yan, Li, Sheng-Nan, Zhu, Hui-Fang, Hu, Zhi-Yan, Zhong, Yan, Gu, Chuan-Sha, Chen, Shi-You, Liu, Teng-fei, Li, Zu-Guo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415763/ https://www.ncbi.nlm.nih.gov/pubmed/28470188 http://dx.doi.org/10.1038/srep46078

Ejemplares similares

DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC
por: Liu, Yan-Ping, et al.
Publicado: (2016)

TRIM37 promotes cell invasion and metastasis by regulating SIP1-mediated epithelial–mesenchymal transition in gastric cancer
por: Chen, Dehu, et al.
Publicado: (2018)

Anlotinib Downregulates RGC32 Which Provoked by Bevacizumab
por: Liu, Zhujun, et al.
Publicado: (2022)

MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression
por: Zu, Chao, et al.
Publicado: (2017)

Serum RGC-32 in children with systemic lupus erythematosus
por: Huang, Bingxue, et al.
Publicado: (2023)

Role of C5b-9 and RGC-32 in Cancer
por: Vlaicu, Sonia I., et al.
Publicado: (2019)

RGC-32 Regulates Generation of Reactive Astrocytes in Experimental Autoimmune Encephalomyelitis
por: Tatomir, Alexandru, et al.
Publicado: (2021)

Loss of Response Gene to Complement 32 (RGC-32) in Diabetic Mouse Retina Is Involved in Retinopathy Development
por: Liao, Wen-Ling, et al.
Publicado: (2018)

Role of RGC-32 in multiple sclerosis and neuroinflammation – few answers and many questions
por: Tatomir, Alexandru, et al.
Publicado: (2022)

Thalidomide Inhibits TGF-β1-induced Epithelial to Mesenchymal Transition in Alveolar Epithelial Cells via Smad-Dependent and Smad-Independent Signaling Pathways
por: Zhou, Xian-Long, et al.
Publicado: (2017)

TGF-β/SMAD4-Regulated LncRNA-LINP1 Inhibits Epithelial-Mesenchymal Transition in Lung Cancer
por: Zhang, Chong, et al.
Publicado: (2018)

MicroRNA-32-5p inhibits epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting SMAD family 3
por: Zhang, Jin-Xing, et al.
Publicado: (2021)

Upregulation of the Cell-Cycle Regulator RGC-32 in Epstein-Barr Virus-Immortalized Cells
por: Schlick, Sandra N., et al.
Publicado: (2011)

Stress-induced epinephrine promotes epithelial-to-mesenchymal transition and stemness of CRC through the CEBPB/TRIM2/P53 axis
por: Zhou, Zili, et al.
Publicado: (2022)

Repression of Smad3 by silencing Robo1 attenuates epithelial-mesenchymal transition in tracheobronchial stenosis
por: He, Chunyan, et al.
Publicado: (2023)

Resveratrol Suppresses Epithelial-Mesenchymal Transition in GBM by Regulating Smad-Dependent Signaling
por: Song, Yang, et al.
Publicado: (2019)

20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial–mesenchymal transition
por: Yuan, Yihang, et al.
Publicado: (2020)

HOXC6 gene silencing inhibits epithelial-mesenchymal transition and cell viability through the TGF-β/smad signaling pathway in cervical carcinoma cells
por: Zhang, Feng, et al.
Publicado: (2018)

Pumilio directs deadenylation-associated translational repression of the cyclin-dependent kinase 1 activator RGC-32
por: Brocard, Michèle, et al.
Publicado: (2018)

RGC-32 Acts as a Hub to Regulate the Transcriptomic Changes Associated With Astrocyte Development and Reactive Astrocytosis
por: Tatomir, Alexandru, et al.
Publicado: (2021)

Role of Smad3 signaling in the epithelial-mesenchymal transition of the lens epithelium following injury
por: Meng, Fanlan, et al.
Publicado: (2018)

HUNK inhibits epithelial-mesenchymal transition of CRC via direct phosphorylation of GEF-H1 and activating RhoA/LIMK-1/CFL-1
por: Han, Xiaoqi, et al.
Publicado: (2023)

Sphingomyelin synthase 1 regulates the epithelial-to-mesenchymal transition mediated by the TGF-β/Smad pathway in MDA-MB-231 cells
por: Liu, Shuang, et al.
Publicado: (2019)

SMAD4 mutations do not preclude epithelial–mesenchymal transition in colorectal cancer
por: Frey, Patrick, et al.
Publicado: (2021)

MiR-21-5p in Macrophage-Derived Exosomes Targets Smad7 to Promote Epithelial Mesenchymal Transition of Airway Epithelial Cells
por: Li, Xiang, et al.
Publicado: (2021)

CDCA7 promotes TGF‐β‐induced epithelial–mesenchymal transition via transcriptionally regulating Smad4/Smad7 in ESCC
por: Li, Hongyi, et al.
Publicado: (2022)

DYRK1A reinforces epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma via cooperatively activating STAT3 and SMAD
por: Li, Yang-ling, et al.
Publicado: (2022)

SIP trunking
por: Hattingh, Christina, et al.
Publicado: (2010)

Lyn regulates epithelial–mesenchymal transition in CS-exposed model through Smad2/3 signaling
por: Liang, Xiaobo, et al.
Publicado: (2019)

SipB-SipC Complex Is Essential for Translocon Formation
por: Myeni, Sebenzile K., et al.
Publicado: (2013)

Bleomycin (BLM) Induces Epithelial-to-Mesenchymal Transition in Cultured A549 Cells via the TGF-β/Smad Signaling Pathway
por: Chen, Kui-Jun, et al.
Publicado: (2016)

Epithelial-to-mesenchymal transition in the development of endometriosis
por: Yang, Yan-Meng, et al.
Publicado: (2017)

GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition
por: Zhou, Xiao-Ming, et al.
Publicado: (2017)

Silencing SOX2 Induced Mesenchymal-Epithelial Transition and Its Expression Predicts Liver and Lymph Node Metastasis of CRC Patients
por: Han, Xu, et al.
Publicado: (2012)

RAMS11 promotes CRC through mTOR-dependent inhibition of autophagy, suppression of apoptosis, and promotion of epithelial-mesenchymal transition
por: Islam Khan, Md Zahirul, et al.
Publicado: (2021)

Sasanquasaponin inhibited epithelial to mesenchymal transition in prostate cancer by regulating the PI3K/Akt/mTOR and Smad pathways
por: Li, Wenfeng, et al.
Publicado: (2022)

Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-α
por: Câmara, Joana, et al.
Publicado: (2010)

The roles of signaling pathways in epithelial-to-mesenchymal transition of PVR
por: Chen, Zhenna, et al.
Publicado: (2015)

SMYD3 induces sorafenib resistance by activating SMAD2/3-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
por: Wang, Shanshan, et al.
Publicado: (2023)

IL-32 induces epithelial-mesenchymal transition by triggering endoplasmic reticulum stress in A549 cells
por: Gong, Ling, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o0pqvsjdfj5e4io8a4gs54v13j